Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
QuintilesIMS
Federal Trade Commission
Deloitte
Medtronic
Citi
Boehringer Ingelheim
Chinese Patent Office
Moodys
Cipla

Generated: October 17, 2017

DrugPatentWatch Database Preview

DARVOCET Drug Profile

« Back to Dashboard

Which patents cover Darvocet, and what generic Darvocet alternatives are available?

Darvocet is a drug marketed by Aaipharma Llc and Xanodyne Pharm and is included in three NDAs.

The generic ingredient in DARVOCET is acetaminophen; propoxyphene napsylate. There are sixty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetaminophen; propoxyphene napsylate profile page.

Summary for Tradename: DARVOCET

US Patents:0
Applicants:2
NDAs:3
Bulk Api Vendors: see list98
Clinical Trials: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DARVOCET at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aaipharma Llc
DARVOCET
acetaminophen; propoxyphene hydrochloride
TABLET;ORAL016844-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Xanodyne Pharm
DARVOCET-N 50
acetaminophen; propoxyphene napsylate
TABLET;ORAL017122-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Xanodyne Pharm
DARVOCET A500
acetaminophen; propoxyphene napsylate
TABLET;ORAL076429-001Sep 10, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Xanodyne Pharm
DARVOCET-N 100
acetaminophen; propoxyphene napsylate
TABLET;ORAL017122-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Healthtrust
Express Scripts
Fuji
US Army
Novartis
Baxter
Merck
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot